To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C20orf108TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
415 supporting clones for gene C20orf108 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DN998575 bone marrow .a 1 to 737 1 to 736 exact tiling clone,   736/736
(100 %)
5 diff
(99.4 %id)
DB500825 hypothalamus .a 17 to 502 1 to 486       486/486
(100 %)
0 diff
(100 %id)
NM_080821.2   .a 17 to 3040 1 to 3024   RefSeq, AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 3024/3024
(100 %)
0 diff
(100 %id)
AK314768 breast, tumor tissue .a 32 to 674 1 to 643       643/643
(100 %)
0 diff
(100 %id)
DA074237 cerebellum .a 32 to 536 2 to 507   capped   506/506
(100 %)
2 diff
(99.7 %id)
DB003483 breast, tumor tissue .a 33 to 247 2 to 216   capped   215/215
(100 %)
0 diff
(100 %id)
CB988401 Human Placenta, placenta .a 37 to 772 24 to 769       746/789
(94 %)
24 diff
(97.0 %id)
CB959793 Human Placenta, placenta .a 37 to 702 24 to 693       670/782
(85 %)
16 diff
(98.0 %id)
AL534902 brain, fetal brain .a 39 to 1134 1 to 1086       1086/1098
(98 %)
27 diff
(97.6 %id)
BI562603 testis .a 39 to 594 1 to 568       569/969
(58 %)
44 diff
(95.5 %id)
TI_44351019   .a 44 to 658 118 to 754       638/1081
(59 %)
80 diff
(92.6 %id)
BP274101 Kidney .a 50 to 632 1 to 583       583/583
(100 %)
0 diff
(100 %id)
AW160993 brain, frontal lobe .a 52 to 492 1 to 441       441/441
(100 %)
0 diff
(100 %id)
AJ311123   .a 56 to 3040 1 to 2984   tiling clone, AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 2984/2984
(100 %)
2 diff
(100.0 %id)
BC017725 Lung, carcinoma, large cellundifferentiated. .a 60 to 2716 1 to 2657   available from MGC, AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 2657/2657
(100 %)
3 diff
(99.9 %id)
BQ678888 melanotic melanoma, cell line, skin .a 61 to 568 1 to 509       509/1004
(50 %)
18 diff
(98.3 %id)
CB996286 placenta, pre-eclamptic placenta .a 64 to 580 28 to 550       523/862
(60 %)
32 diff
(96.3 %id)
CD109563 Human Placenta, placenta .a 64 to 767 28 to 736       709/806
(87 %)
13 diff
(98.4 %id)
CF994599 Human Placenta, placenta .a 64 to 781 28 to 766       739/811
(91 %)
44 diff
(94.6 %id)
BP275877 Kidney .a 64 to 634 1 to 570       570/581
(98 %)
10 diff
(98.3 %id)
DA056996 cerebellum .a 65 to 514 2 to 453   capped   452/452
(100 %)
4 diff
(99.2 %id)
DA114635 cerebellum .a 65 to 337 2 to 275   capped   274/275
(99 %)
5 diff
(98.2 %id)
DA707401   .a 65 to 356 2 to 293   capped   292/292
(100 %)
0 diff
(100 %id)
DB460173 testis .a 67 to 531 1 to 465       465/465
(100 %)
3 diff
(99.4 %id)
BG773534 testis .a 67 to 649 1 to 584       584/595
(98 %)
10 diff
(98.4 %id)
BM472525 melanotic melanoma, skin .a 69 to 567 34 to 538       505/988
(51 %)
26 diff
(97.4 %id)
AK075565   .a 70 to 2716 1 to 2646       2646/2646
(100 %)
3 diff
(99.9 %id)
DB495937 hypothalamus .a 70 to 550 1 to 481       481/481
(100 %)
1 diff
(99.8 %id)
BF978071 melanotic melanoma, high MDR, skin .a 70 to 735 1 to 666       666/905
(73 %)
15 diff
(98.4 %id)
BF978258 melanotic melanoma, high MDR, skin .a 70 to 737 1 to 659       659/886
(74 %)
22 diff
(97.6 %id)
CF593384 Human Placenta, placenta .a 70 to 767 29 to 735       707/897
(78 %)
17 diff
(98.2 %id)
CF593383 Human Placenta, placenta .a 70 to 792 29 to 756       728/893
(81 %)
18 diff
(98.0 %id)
DA736356   .a 71 to 759 2 to 691   capped   690/691
(99 %)
5 diff
(99.3 %id)
DA485582 brain .a 77 to 648 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BM924756 pooled colon, kidney, stomach .a 78 to 860 11 to 800       790/1236
(63 %)
35 diff
(97.2 %id)
BE879420 large cell carcinoma, undifferentiated, lung .a 82 to 726 1 to 640       640/894
(71 %)
32 diff
(96.5 %id)
BX458517 placenta .a 86 to 1108 1 to 1026       1026/1137
(90 %)
27 diff
(97.7 %id)
BQ680669 melanotic melanoma, cell line, skin .a 86 to 457 1 to 372       372/1062
(35 %)
3 diff
(99.8 %id)
BQ677353 melanotic melanoma, cell line, skin .a 86 to 450 1 to 364       364/1235
(29 %)
12 diff
(99.1 %id)
BU174154 melanotic melanoma, cell line, skin .a 86 to 601 1 to 519       519/1032
(50 %)
18 diff
(98.3 %id)
DA885726   .a 86 to 598 2 to 514   capped   513/513
(100 %)
1 diff
(99.9 %id)
DA666376   .a 90 to 356 2 to 268   capped   267/267
(100 %)
0 diff
(100 %id)
BQ879066 dorsal root ganglia .a 92 to 836 1 to 746       746/975
(76 %)
28 diff
(97.2 %id)
BI759557 pooled colon, kidney, stomach .a 103 to 871 1 to 777       777/777
(100 %)
46 diff
(94.1 %id)
TI_57149575   .a 103 to 871 28 to 804       777/804
(96 %)
30 diff
(96.3 %id)
CD171733 testis .a 104 to 969 1 to 876       876/878
(99 %)
20 diff
(97.8 %id)
BU071677 insulinoma, Pancreas .a 109 to 656 8 to 555       548/555
(98 %)
7 diff
(98.8 %id)
BM462748 melanotic melanoma, skin .a 138 to 622 12 to 496       485/1217
(39 %)
42 diff
(96.6 %id)
BM462765 melanotic melanoma, skin .a 138 to 842 12 to 716   AAA   705/716
(98 %)
9 diff
(98.8 %id)
BQ548930 insulinoma, Pancreas .a 198 to 768 1 to 571       571/571
(100 %)
6 diff
(99.0 %id)
AW183050 pooled .a 372 to 844 478 to 6       473/478
(98 %)
0 diff
(100 %id)
BU929095 placenta .a 372 to 1156 1 to 785       785/785
(100 %)
12 diff
(98.5 %id)
BF204095 muscle, rhabdomyosarcoma .a 380 to 783 1 to 404       404/553
(73 %)
10 diff
(98.2 %id)
BG826887 muscle, rhabdomyosarcoma .a 380 to 998 1 to 619       619/622
(99 %)
3 diff
(99.6 %id)
BF576922 muscle (skeletal) .a 390 to 974 1 to 582       582/874
(66 %)
9 diff
(99.0 %id)
AA321447 bone marrow .a 457 to 751 19 to 316       298/321
(92 %)
8 diff
(97.6 %id)
AW955911   .a 460 to 1107 21 to 669       649/669
(97 %)
6 diff
(99.2 %id)
DA428264 colon .a 518 to 1081 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BQ431501 leiomyosarcoma, uterus .a 555 to 1406 1 to 855       855/855
(100 %)
11 diff
(98.8 %id)
DB183353 liver, tumor tissue .a 634 to 1191 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA942594 Spleen .a 650 to 1218 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
CD244964 White Matter .a 661 to 1540 20 to 908   AAA   889/917
(96 %)
6 diff
(99.4 %id)
AI630447 blood .a 691 to 906 1 to 216       216/216
(100 %)
1 diff
(99.6 %id)
DB182904 liver, tumor tissue .a 697 to 1268 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BI859250 breast, mammary adenocarcinoma, cell line .a 703 to 1497 1 to 796       796/798
(99 %)
17 diff
(97.9 %id)
TI_57188315   .a 703 to 1497 49 to 844       796/798
(99 %)
17 diff
(97.9 %id)
BQ016573 lung, Lung Focal Fibrosis .a 707 to 1384 16 to 693     Submitted on the opposite strand 678/693
(97 %)
6 diff
(99.2 %id)
DB003553 breast, tumor tissue .a 723 to 1258 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
DA479252   .a 737 to 1310 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BI862479 breast, mammary adenocarcinoma, cell line .a 737 to 1543 1 to 795       795/801
(99 %)
20 diff
(97.6 %id)
TI_57192655   .a 737 to 1543 119 to 913       795/801
(99 %)
20 diff
(97.6 %id)
BG033262 breast, mammary adenocarcinoma, cell line .a 756 to 1532 1 to 762       762/976
(78 %)
29 diff
(97.1 %id)
EC440084 Prostate .a 793 to 901 1 to 108       108/108
(100 %)
1 diff
(99.1 %id)
EC493177 Prostate .a 795 to 905 1 to 110       110/110
(100 %)
6 diff
(94.6 %id)
BP289887 lung .a 795 to 1371 1 to 574       574/584
(98 %)
15 diff
(97.5 %id)
EC506863 Prostate .a 796 to 905 1 to 109       109/109
(100 %)
5 diff
(95.5 %id)
DA489296 brain .a 797 to 1336 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
EC471072 Prostate .a 798 to 904 1 to 105       105/105
(100 %)
2 diff
(98.1 %id)
EC472703 Prostate .a 798 to 904 1 to 107       107/107
(100 %)
0 diff
(100 %id)
EC491908 Prostate .a 798 to 905 1 to 106       106/106
(100 %)
2 diff
(98.2 %id)
BM459828 leiomyosarcoma, uterus .a 798 to 1731 1 to 940       940/1064
(88 %)
22 diff
(98.0 %id)
EC531305 Prostate .a 799 to 904 4 to 112       109/112
(97 %)
6 diff
(94.7 %id)
AA279593 germinal center B cell .a 801 to 1221 1 to 421       421/421
(100 %)
0 diff
(100 %id)
EC527065 Prostate .a 804 to 901 17 to 116       100/116
(86 %)
6 diff
(94.9 %id)
BP203350 coronary artery .a 806 to 1335 1 to 530       530/531
(99 %)
2 diff
(99.7 %id)
AA345184 gall bladder .a 810 to 1055 1 to 247       247/247
(100 %)
1 diff
(99.6 %id)
EC496534 Prostate .a 811 to 917 1 to 107       107/107
(100 %)
0 diff
(100 %id)
BP290303 lung .a 822 to 1311 1 to 489       489/584
(83 %)
10 diff
(98.3 %id)
AW516629 ovary, papillary serous ovarian metastasis .a 826 to 1228 22 to 424     Submitted on the opposite strand 403/424
(95 %)
6 diff
(98.6 %id)
AI133137 Liver .a 839 to 1553 724 to 9   AAA   716/725
(98 %)
0 diff
(100 %id)
DA599870   .a 845 to 1398 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
DA265307 caudate nucleus .a 855 to 1416 2 to 563   capped   562/563
(99 %)
1 diff
(99.9 %id)
DA732633   .a 858 to 1625 2 to 782   capped   781/856
(91 %)
23 diff
(97.4 %id)
AA322264 brain, cerebellum .a 865 to 1189 1 to 326       326/326
(100 %)
1 diff
(99.7 %id)
AW277061 ovary, papillary serous ovarian metastasis .a 883 to 1323 9 to 449     Submitted on the opposite strand 441/449
(98 %)
8 diff
(98.3 %id)
AW276837 ovary, papillary serous ovarian metastasis .a 883 to 1342 40 to 499     Submitted on the opposite strand 460/499
(92 %)
6 diff
(98.8 %id)
DA282174 corpus callosum .a 888 to 1462 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BP196237 adrenal gland .a 901 to 1481 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP325992 prostata .a 901 to 1484 1 to 584       584/584
(100 %)
0 diff
(100 %id)
AA036873 uterus .a 919 to 1134 1 to 217       217/217
(100 %)
1 diff
(99.6 %id)
BU194946 melanotic melanoma, skin .a 932 to 1799 1 to 876       876/895
(97 %)
16 diff
(98.3 %id)
AI064697 Liver .a 933 to 1553 630 to 9       622/630
(98 %)
0 diff
(100 %id)
DA602044   .a 934 to 1502 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BG777164 lung, mucoepidermoid carcinoma .a 938 to 1525 1 to 588       588/749
(78 %)
3 diff
(99.6 %id)
CN369422 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 953 to 1716 21 to 784       764/784
(97 %)
6 diff
(99.3 %id)
BM932139 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 973 to 1544 1 to 572   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 572/572
(100 %)
1 diff
(99.9 %id)
CN369425 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 988 to 1705 1 to 716       716/716
(100 %)
2 diff
(99.8 %id)
BU156236 melanotic melanoma, skin .a 1010 to 1911 1 to 904       904/907
(99 %)
13 diff
(98.6 %id)
AI807522 pooled .a 1011 to 1540 528 to 1       528/528
(100 %)
1 diff
(99.9 %id)
BQ432232 melanotic melanoma, skin .a 1034 to 1911 12 to 884       873/886
(98 %)
16 diff
(98.2 %id)
DA571720 whole embryo, mainly head .a 1035 to 1815 2 to 781   capped   780/780
(100 %)
4 diff
(99.5 %id)
BP397995 pancreatic islet .a 1042 to 1541 1 to 500     Submitted on the opposite strand 500/500
(100 %)
1 diff
(99.8 %id)
T79188 liver and spleen .a 1044 to 1538 518 to 1       518/520
(99 %)
29 diff
(94.5 %id)
BP395572 pancreatic islet .a 1048 to 1546 1 to 500     Submitted on the opposite strand 500/500
(100 %)
3 diff
(99.4 %id)
AW161676 brain, frontal lobe .a 1055 to 1546 492 to 1       492/492
(100 %)
1 diff
(99.8 %id)
BI859009 breast, mammary adenocarcinoma, cell line .a 1055 to 1929 1 to 880       880/895
(98 %)
45 diff
(95.0 %id)
TI_57190531   .a 1055 to 1929 59 to 938       880/895
(98 %)
45 diff
(95.0 %id)
AW295579   .a 1057 to 1541 502 to 18   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 485/504
(96 %)
2 diff
(99.7 %id)
BM697537 eye, fetal eyes .a 1061 to 1720 1 to 660     Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 660/660
(100 %)
1 diff
(99.9 %id)
BP226711   .a 1065 to 1646 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AU122227 mammary gland .a 1089 to 1920 2 to 833   capped   832/832
(100 %)
4 diff
(99.6 %id)
BE217784 carcinoid, lung .a 1090 to 1539 451 to 2       450/451
(99 %)
0 diff
(100 %id)
BE218195 carcinoid, lung .a 1090 to 1540 451 to 1       451/451
(100 %)
2 diff
(99.6 %id)
BE549622 carcinoid, lung .a 1090 to 1540 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AA987991 carcinoid, lung .a 1091 to 1543 453 to 1       453/462
(98 %)
0 diff
(100 %id)
BE674082 carcinoid, lung .a 1091 to 1543 454 to 2       453/454
(99 %)
0 diff
(100 %id)
BF433504 carcinoid, lung .a 1091 to 1543 454 to 2       453/454
(99 %)
0 diff
(100 %id)
AI335941 uterus .a 1103 to 1539 439 to 3       437/439
(99 %)
0 diff
(100 %id)
BP252376 Kidney .a 1104 to 1674 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
BP213656 cerebrum .a 1105 to 1662 1 to 557       557/557
(100 %)
7 diff
(98.8 %id)
CN369426 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1105 to 1377 1 to 273       273/273
(100 %)
0 diff
(100 %id)
CN369424 embryonic stem cells, cell lines H1, H7, andH9 .a 1127 to 1813 1 to 688       688/688
(100 %)
1 diff
(99.9 %id)
AI223329 pooled .a 1129 to 1541 413 to 1       413/413
(100 %)
2 diff
(99.6 %id)
AA642407 germinal center B cell .a 1131 to 1539 409 to 1       409/409
(100 %)
0 diff
(100 %id)
BP233942 coronary artery .a 1136 to 1723 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
AI217681 pooled .a 1136 to 1541 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AI871571 carcinoid, lung .a 1137 to 1543 407 to 1       407/407
(100 %)
0 diff
(100 %id)
BP375881 uterus .a 1138 to 1716 1 to 581       581/581
(100 %)
7 diff
(98.8 %id)
BE219569 carcinoid, lung .a 1140 to 1543 404 to 1       404/404
(100 %)
0 diff
(100 %id)
AI032936 liver and spleen .a 1141 to 1541 401 to 1       401/401
(100 %)
0 diff
(100 %id)
BU161746 melanotic melanoma, skin .a 1151 to 2051 1 to 904       904/905
(99 %)
9 diff
(99.1 %id)
AA926653 pooled .a 1156 to 1541 386 to 1       386/386
(100 %)
0 diff
(100 %id)
AL534901 brain, fetal brain .a 2020 to 2934 925 to 6       920/929
(99 %)
0 diff
(100 %id)
BQ548636 insulinoma, Pancreas .a 2064 to 2719 656 to 1       656/656
(100 %)
1 diff
(99.9 %id)
DB358601 whole embryo, mainly head .a 2176 to 2716 539 to 1       539/539
(100 %)
6 diff
(98.9 %id)
BU073224 insulinoma, Pancreas .a 2184 to 2741 558 to 1       558/558
(100 %)
4 diff
(99.3 %id)
DB368823   .a 2207 to 2716 509 to 1       509/509
(100 %)
2 diff
(99.7 %id)
BU735722 eye, fetal eyes .a 2474 to 2716 261 to 19   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 243/243
(100 %)
0 diff
(100 %id)
DB361573 mammary gland .a 2486 to 3040 566 to 1   tiling clone,   566/574
(98 %)
18 diff
(96.9 %id)
DB364205   .a 2511 to 3047 537 to 1       537/540
(99 %)
21 diff
(96.2 %id)
AI761399 pooled .b 1 to 531 532 to 1 exact tiling clone,   532/532
(100 %)
2 diff
(99.7 %id)
AI185932 lung .b 136 to 614 490 to 12   tiling clone, AAA   479/479
(100 %)
0 diff
(100 %id)
AI249046 liver and spleen .b 165 to 536 375 to 4       372/375
(99 %)
0 diff
(100 %id)
H71789 liver and spleen .b 172 to 532 362 to 1       362/364
(99 %)
3 diff
(99.2 %id)
AI363864 anaplastic oligodendroglioma, brain .b 295 to 614 319 to 1       319/319
(100 %)
1 diff
(99.7 %id)
AI692262 adenocarcinoma, Pancreas .b 461 to 607 151 to 5       147/151
(97 %)
0 diff
(100 %id)
BX109823 liver and spleen .c-u 1 to 537 1 to 538 exact tiling clone,   538/543
(99 %)
3 diff
(99.5 %id)
H56991 liver and spleen .c-u 2 to 388 1 to 391 A66G P68T     391/392
(99 %)
5 diff
(98.8 %id)
BG576222 breast, mammary adenocarcinoma, cell line .c-u 765 to 1549 1 to 795   tiling clone,   795/928
(85 %)
7 diff
(99.3 %id)
BQ940713 sciatic nerve .c-u 786 to 1576 1 to 798   tiling clone,   798/906
(88 %)
13 diff
(98.6 %id)
AA722424 heart .c-u 799 to 1170 372 to 1       372/372
(100 %)
1 diff
(99.8 %id)
BE904060 epithelioid carcinoma, Pancreas .c-u 801 to 1451 1 to 651       651/651
(100 %)
0 diff
(100 %id)
DB294298   .c-u 801 to 1540 2 to 740   capped   739/739
(100 %)
5 diff
(99.4 %id)
AA337393 endometrium .c-u 803 to 1053 1 to 253       253/257
(98 %)
4 diff
(98.5 %id)
BG696297 skin .c-u 803 to 1575 1 to 774       774/774
(100 %)
2 diff
(99.8 %id)
AW952616   .c-u 804 to 1291 1 to 487       487/489
(99 %)
5 diff
(99.0 %id)
AI911835 colon .c-u 806 to 1171 366 to 1       366/366
(100 %)
1 diff
(99.8 %id)
BI089479 cervix .c-u 807 to 1546 1 to 742       742/742
(100 %)
10 diff
(98.7 %id)
BP301333   .c-u 821 to 1399 1 to 580       580/583
(99 %)
9 diff
(98.5 %id)
BP303120   .c-u 825 to 1331 1 to 508       508/587
(86 %)
19 diff
(96.8 %id)
H56903 liver and spleen .c-u 836 to 1169 348 to 4       345/362
(95 %)
0 diff
(100 %id)
BP338093 Spleen .c-u 836 to 1420 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
N25210 melanocyte .c-u 842 to 1173 332 to 1       332/335
(99 %)
0 diff
(100 %id)
CN369423 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c-u 851 to 1632 1 to 782       782/782
(100 %)
0 diff
(100 %id)
CF121263 CNCAP(3)T-225 cell line, Prostate .c-u 857 to 1536 1 to 679       679/679
(100 %)
5 diff
(99.3 %id)
CF122008 CNCAP(3)T-225 cell line, Prostate .c-u 857 to 1493 1 to 637       637/637
(100 %)
27 diff
(95.8 %id)
TI_154180279   .c-u 864 to 1676 70 to 876       807/807
(100 %)
11 diff
(98.7 %id)
TI_154181420   .c-u 864 to 1753 71 to 940       870/955
(91 %)
66 diff
(93.1 %id)
AA347145 heart .c-u 866 to 1165 1 to 301       301/301
(100 %)
1 diff
(99.7 %id)
AA069947   .c-u 921 to 1171 1 to 252       252/252
(100 %)
1 diff
(99.7 %id)
AA070043   .c-u 921 to 1171 1 to 250   fully sequenced,   250/250
(100 %)
1 diff
(99.6 %id)
CX761696 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c-u 921 to 1651 1 to 729     Submitted on the opposite strand 729/740
(98 %)
6 diff
(99.2 %id)
L17329 Liver .c-u 923 to 1170 1 to 249       249/249
(100 %)
1 diff
(99.6 %id)
T69818 liver and spleen .c-u 950 to 1167 219 to 1       219/219
(100 %)
4 diff
(98.2 %id)
BE890399 melanotic melanoma, skin .c-u 952 to 1724 1 to 763       763/859
(88 %)
27 diff
(96.9 %id)
CD635967   .c-u 962 to 1372 8 to 414       407/414
(98 %)
6 diff
(98.6 %id)
CD635969   .c-u 962 to 1373 8 to 415       408/415
(98 %)
6 diff
(98.6 %id)
AL133555 testis .c-u 963 to 2669 1 to 1707   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1707/1707
(100 %)
0 diff
(100 %id)
BP332816 salivary gland .c-u 970 to 1511 1 to 542       542/561
(96 %)
10 diff
(98.3 %id)
AA070816   .c-u 985 to 1170 186 to 1   fully sequenced,   186/186
(100 %)
0 diff
(100 %id)
BF306990 muscle, rhabdomyosarcoma .c-u 988 to 1783 1 to 789       789/979
(80 %)
6 diff
(99.4 %id)
BP330729 rectum .c-u 990 to 1571 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP330895 rectum .c-u 990 to 1571 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ675129 epidermoid carcinoma, cell line, salivary gland .c-u 1023 to 1947 1 to 935       935/946
(98 %)
18 diff
(98.1 %id)
DA083940 cerebellum .c-u 1026 to 1502 2 to 479   capped   478/478
(100 %)
2 diff
(99.6 %id)
BG748007 eye, normal pigmented retinal epithelium .c-u 1051 to 1893 1 to 840       840/842
(99 %)
12 diff
(98.6 %id)
AL120698 melanoma (MeWo cell line) .c-u 1075 to 1704 1 to 630       630/630
(100 %)
0 diff
(100 %id)
AL134898 melanoma (MeWo cell line) .c-u 1075 to 1701 1 to 626       626/626
(100 %)
1 diff
(99.9 %id)
DR155544 human embryonic stem cells differentiated toan early endodermal cell type .c-u 1076 to 1872 1 to 797       797/797
(100 %)
1 diff
(99.9 %id)
BM797036 Ascites, stomach .c-u 1089 to 1506 1 to 418       418/418
(100 %)
0 diff
(100 %id)
CF144365 CNCAP(3)T-225 cell line, Prostate .c-u 1111 to 1535 1 to 426       426/426
(100 %)
10 diff
(97.7 %id)
CF144445 CNCAP(3)T-225 cell line, Prostate .c-u 1111 to 1577 1 to 468       468/468
(100 %)
7 diff
(98.6 %id)
TI_154176356   .c-u 1118 to 1784 91 to 759       669/1068
(62 %)
34 diff
(96.9 %id)
TI_154176452   .c-u 1118 to 1718 80 to 685       606/1357
(44 %)
15 diff
(98.9 %id)
BP291017 lung .c-u 1142 to 1649 1 to 508       508/564
(90 %)
11 diff
(98.1 %id)
BP871250 embryonal kidney .c-u 1146 to 1478 1 to 332       332/332
(100 %)
1 diff
(99.7 %id)
BG280892 melanotic melanoma, skin .c-u 1190 to 1863 1 to 684       684/1100
(62 %)
31 diff
(97.2 %id)
BI252094 hepatocellular carcinoma, cell line, Liver .c-u 1192 to 2081 1 to 893       893/893
(100 %)
29 diff
(96.8 %id)
AA351825 brain .c-u 1199 to 1590 1 to 391       391/391
(100 %)
2 diff
(99.5 %id)
BF327209 breast_normal .c-u 1200 to 1351 16 to 167       152/167
(91 %)
6 diff
(96.5 %id)
BE388951 endometrium, adenocarcinoma cell line, uterus .c-u 1210 to 1892 1 to 676       676/683
(98 %)
12 diff
(98.3 %id)
BE388348 endometrium, adenocarcinoma cell line, uterus .c-u 1210 to 1750 1 to 542       542/545
(99 %)
4 diff
(99.3 %id)
BE386415 melanotic melanoma, skin .c-u 1210 to 1892 1 to 681       681/706
(96 %)
10 diff
(98.6 %id)
BE729971 melanotic melanoma, skin .c-u 1210 to 1911 1 to 702       702/702
(100 %)
3 diff
(99.6 %id)
BU663257 blood .c-u 1246 to 1908 7 to 668       662/668
(99 %)
6 diff
(99.2 %id)
AA147801   .c-u 1249 to 1815 1 to 562       562/562
(100 %)
6 diff
(99.0 %id)
N42508 melanocyte .c-u 1259 to 1714 1 to 457       457/457
(100 %)
1 diff
(99.8 %id)
BU659563 blood .c-u 1280 to 1905 10 to 635       626/635
(98 %)
6 diff
(99.1 %id)
BQ894725 melanotic melanoma, cell line, skin .c-u 1283 to 2162 1 to 884       884/895
(98 %)
11 diff
(98.8 %id)
BU168562 melanotic melanoma, cell line, skin .c-u 1283 to 2034 1 to 756       756/883
(85 %)
15 diff
(98.4 %id)
BU196497 melanotic melanoma, cell line, skin .c-u 1283 to 2131 1 to 856       856/857
(99 %)
11 diff
(98.8 %id)
BQ679538 melanotic melanoma, cell line, skin .c-u 1283 to 1988 1 to 706       706/916
(77 %)
4 diff
(99.6 %id)
BQ678625 melanotic melanoma, cell line, skin .c-u 1283 to 1933 1 to 653       653/942
(69 %)
22 diff
(97.7 %id)
BQ680003 melanotic melanoma, cell line, skin .c-u 1283 to 1849 1 to 568       568/927
(61 %)
12 diff
(98.8 %id)
EC542751 Prostate .c-u 1285 to 1379 16 to 106       91/106
(85 %)
6 diff
(94.4 %id)
AA151904 colon, tumor .c-u 1302 to 1805 1 to 508   fully sequenced, Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 508/508
(100 %)
9 diff
(98.3 %id)
BX479972   .c-u 1307 to 1852 1 to 547       547/547
(100 %)
2 diff
(99.7 %id)
BF671155 muscle (skeletal) .c-u 1324 to 1934 1 to 605       605/865
(69 %)
19 diff
(97.9 %id)
BI438923 Pancreas, Purified pancreatic islet .c-u 1338 to 1922 11 to 595       585/595
(98 %)
6 diff
(99.0 %id)
W21218 lung .c-u 1350 to 1589 1 to 241       241/241
(100 %)
1 diff
(99.6 %id)
AA082509   .c-u 1390 to 1598 1 to 209       209/209
(100 %)
1 diff
(99.6 %id)
BX414632 thymus .c-u 1410 to 1954 971 to 422       550/984
(55 %)
0 diff
(100 %id)
BU161670 melanotic melanoma, skin .c-u 1413 to 2155 1 to 752       752/937
(80 %)
31 diff
(96.7 %id)
CB163203 Liver .c-u 1452 to 2058 1 to 607       607/607
(100 %)
0 diff
(100 %id)
AW368725 head_neck .c-u 1467 to 1871 1 to 405       405/405
(100 %)
2 diff
(99.6 %id)
BE379219 endometrium, adenocarcinoma cell line, uterus .c-u 1514 to 2149 1 to 644       644/645
(99 %)
31 diff
(95.2 %id)
TI_149287520   .c-u 1522 to 2371 899 to 57       843/1177
(71 %)
0 diff
(100 %id)
TI_154179848   .c-u 1530 to 2368 881 to 48     Submitted on the opposite strand 834/928
(89 %)
0 diff
(100 %id)
CB146470 Liver .c-u 1539 to 2060 1 to 522       522/522
(100 %)
0 diff
(100 %id)
AA477364.
matches multiple genes
ovarian tumor, ovary .c-u 1548 to 1892 1 to 345     also hits gene SCNN1AandTNFRSF1A 345/345
(100 %)
1 diff
(99.8 %id)
BF928261 nervous_tumor .c-u 1553 to 1807 261 to 7     Submitted on the opposite strand 255/261
(97 %)
0 diff
(100 %id)
BE781525 eye, retinoblastoma .c-u 1553 to 1749 436 to 640       601/644
(93 %)
36 diff
(94.5 %id)
AV655004 corresponding non cancerous liver tissue .c-u 1560 to 1928 1 to 369     Submitted on the opposite strand 369/369
(100 %)
0 diff
(100 %id)
AA304167 aorta .c-u 1568 to 1922 1 to 359       359/360
(99 %)
6 diff
(98.4 %id)
TI_154091541   .c-u 1571 to 2368 858 to 64       795/1021
(77 %)
0 diff
(100 %id)
AA147558 uterus .c-u 1588 to 1953 1 to 369   fully sequenced,   369/369
(100 %)
1 diff
(99.8 %id)
AW328251 cervix .c-u 1588 to 2090 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
CB157165 Liver .c-u 1593 to 2225 1 to 633       633/633
(100 %)
0 diff
(100 %id)
EL954230 eyeball .c-u 1620 to 2041 20 to 447       428/447
(95 %)
6 diff
(98.7 %id)
EC480697 Prostate .c-u 1633 to 1733 1 to 101       101/101
(100 %)
0 diff
(100 %id)
EC495409 Prostate .c-u 1633 to 1733 1 to 100       100/100
(100 %)
1 diff
(99.0 %id)
EC524251 Prostate .c-u 1633 to 1733 1 to 101       101/101
(100 %)
0 diff
(100 %id)
TI_149280393   .c-u 1638 to 2345 793 to 86   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 708/708
(100 %)
1 diff
(99.9 %id)
W16763 lung .c-u 1641 to 2014 1 to 370   fully sequenced,   370/370
(100 %)
3 diff
(99.2 %id)
BM990513 lung, Metastatic Chondrosarcoma .c-u 1657 to 2345 705 to 19   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 687/696
(98 %)
2 diff
(99.8 %id)
BU679182 lung, Primary Lung Epithelial Cells .c-u 1659 to 2345 705 to 19   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 687/687
(100 %)
1 diff
(99.9 %id)
T57422 fetal spleen, Spleen .c-u 1662 to 1976 1 to 331   fully sequenced,   331/331
(100 %)
10 diff
(97.0 %id)
CD635968   .c-u 1666 to 2284 626 to 11       616/631
(97 %)
0 diff
(100 %id)
BE765837 nervous_tumor .c-u 1667 to 1918 252 to 1       252/256
(98 %)
1 diff
(99.7 %id)
CD635970   .c-u 1673 to 2284 618 to 12       607/618
(98 %)
0 diff
(100 %id)
BF807662 colon_ins .c-u 1678 to 2087 1 to 411       411/411
(100 %)
8 diff
(98.1 %id)
W73907 heart .c-u 1678 to 1932 1 to 264   fully sequenced,   264/264
(100 %)
1 diff
(99.7 %id)
BP268749 thyroid .c-u 1678 to 2260 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP269183 thyroid .c-u 1678 to 2223 1 to 548       548/553
(99 %)
4 diff
(99.3 %id)
H55828 liver and spleen .c-u 1682 to 2055 1 to 377   fully sequenced,   377/377
(100 %)
3 diff
(99.3 %id)
T11823   .c-u 1691 to 2207 9 to 512       504/512
(98 %)
6 diff
(98.9 %id)
AA196016 muscle, skeletal muscle .c-u 1694 to 2270 1 to 569       569/595
(95 %)
17 diff
(97.2 %id)
BM972829 lung .c-u 1698 to 2345 664 to 19   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 646/646
(100 %)
3 diff
(99.6 %id)
BQ722375 sympathetic trunk .c-u 1701 to 2352 1 to 655       655/919
(71 %)
22 diff
(97.7 %id)
BQ926053 large cell carcinoma, lung .c-u 1702 to 2194 584 to 92     Submitted on the opposite strand 493/1249
(39 %)
0 diff
(100 %id)
BF978447 melanotic melanoma, high MDR, skin .c-u 1710 to 2357 1 to 651       651/691
(94 %)
10 diff
(98.6 %id)
BG432350 Kidney .c-u 1717 to 2372 1 to 658       658/879
(74 %)
16 diff
(98.2 %id)
BM726467 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 1727 to 2369 1 to 643   fully sequenced,   643/643
(100 %)
3 diff
(99.6 %id)
AV652960 corresponding non cancerous liver tissue .c-u 1729 to 2141 1 to 413     Submitted on the opposite strand 413/413
(100 %)
0 diff
(100 %id)
CF529697 placenta .c-u 1753 to 1964 217 to 6       212/217
(97 %)
0 diff
(100 %id)
EH325412   .c-u 1760 to 1824 1 to 65       65/65
(100 %)
0 diff
(100 %id)
AA100970   .c-u 1775 to 2346 573 to 1       573/575
(99 %)
3 diff
(99.5 %id)
CF147249 CNCAP(3)T-225 cell line, Prostate .c-u 1779 to 2344 566 to 1     Submitted on the opposite strand 566/566
(100 %)
2 diff
(99.7 %id)
AA421553.
matches multiple genes
  .c-u 1781 to 2254 1 to 474     also hits gene FSTL3 474/474
(100 %)
0 diff
(100 %id)
BM544992 ovary (pool of 3) .c-u 1781 to 2676 18 to 920       903/922
(97 %)
9 diff
(99.1 %id)
BM311052 Pancreas, Purified pancreatic islet .c-u 1792 to 2268 1 to 477       477/477
(100 %)
0 diff
(100 %id)
DB360732.
matches multiple genes
mammary gland .c-u 1795 to 2345 549 to 1     also hits gene CDKAL1 549/571
(96 %)
8 diff
(98.6 %id)
AA149767 colon, tumor .c-u 1800 to 2345 553 to 15   fully sequenced, AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 539/539
(100 %)
19 diff
(96.5 %id)
BI438596 Pancreas, Purified pancreatic islet .c-u 1813 to 2346 534 to 1       534/534
(100 %)
0 diff
(100 %id)
BM311639 Pancreas, Purified pancreatic islet .c-u 1813 to 2348 536 to 1       536/536
(100 %)
0 diff
(100 %id)
BU782813 insulinoma, Pancreas .c-u 1813 to 2345 550 to 18   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 533/533
(100 %)
0 diff
(100 %id)
DB384353   .c-u 1813 to 2345 533 to 1       533/537
(99 %)
12 diff
(97.8 %id)
AW962739   .c-u 1816 to 2345 1 to 529   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 529/529
(100 %)
4 diff
(99.3 %id)
T35192 prostate gland .c-u 1816 to 2145 1 to 328       328/338
(97 %)
2 diff
(99.5 %id)
H80762 melanocyte .c-u 1818 to 2030 1 to 213       213/219
(97 %)
1 diff
(99.6 %id)
BI861171 breast, mammary adenocarcinoma, cell line .c-u 1819 to 2366 1 to 548       548/762
(71 %)
8 diff
(99.0 %id)
TI_57192106   .c-u 1819 to 2366 44 to 591       548/762
(71 %)
8 diff
(99.0 %id)
AI749541 colon .c-u 1820 to 2348 530 to 1       530/530
(100 %)
7 diff
(98.7 %id)
BM701412 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 1825 to 2014 1 to 190   fully sequenced,   190/190
(100 %)
1 diff
(99.5 %id)
BP395258 pancreatic islet .c-u 1830 to 2330 1 to 503     Submitted on the opposite strand 503/503
(100 %)
3 diff
(99.5 %id)
BQ326814 colon_normal .c-u 1836 to 1946 1 to 112       112/112
(100 %)
3 diff
(97.4 %id)
W47523 senescent fibroblast .c-u 1843 to 2033 1 to 191   fully sequenced,   191/191
(100 %)
0 diff
(100 %id)
T34852 brain .c-u 1845 to 2083 1 to 239       239/239
(100 %)
0 diff
(100 %id)
BP398698 pancreatic islet .c-u 1851 to 2345 1 to 495     Submitted on the opposite strand 495/495
(100 %)
5 diff
(99.0 %id)
CV574106 cornea, eye .c-u 1855 to 2345 1 to 491   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 491/493
(99 %)
1 diff
(99.8 %id)
AI370937 brain, glioblastoma (pooled) .c-u 1856 to 2347 492 to 1       492/492
(100 %)
0 diff
(100 %id)
EC558901 Prostate .c-u 1861 to 1972 1 to 112       112/112
(100 %)
0 diff
(100 %id)
AA918649 Kidney .c-u 1868 to 2348 480 to 1       480/480
(100 %)
3 diff
(99.4 %id)
CB045070 colon, juvenile granulosa tumor .c-u 1875 to 2345 487 to 17   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 471/471
(100 %)
0 diff
(100 %id)
AA576016 breast, breast tumor .c-u 1877 to 2345 469 to 1       469/469
(100 %)
0 diff
(100 %id)
N93764 lung .c-u 1882 to 2348 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
AA102347   .c-u 1886 to 2355 470 to 1       470/474
(99 %)
2 diff
(99.6 %id)
DB525614 testis .c-u 1901 to 2345 1 to 445     Submitted on the opposite strand 445/445
(100 %)
1 diff
(99.8 %id)
W74769 heart .c-u 1902 to 2348 447 to 1   fully sequenced,   447/447
(100 %)
3 diff
(99.4 %id)
N78229 liver and spleen .c-u 1907 to 2365 1 to 465   fully sequenced,   465/465
(100 %)
5 diff
(99.0 %id)
AA773313 lung, lung carcinoma .c-u 1907 to 1975 1 to 69     Submitted on the opposite strand 69/69
(100 %)
0 diff
(100 %id)
EL952643 eyeball .c-u 1908 to 2345 1 to 437   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 437/437
(100 %)
5 diff
(98.9 %id)
BG114366 Bone, osteosarcoma, cell line .c-u 1911 to 2630 1 to 732       732/981
(74 %)
46 diff
(95.4 %id)
AI927855 normal prostate, Prostate .c-u 1913 to 2350 437 to 1       437/437
(100 %)
4 diff
(99.1 %id)
AA342685 Spleen .c-u 1917 to 2345 429 to 1       429/429
(100 %)
2 diff
(99.6 %id)
AA156430 uterus .c-u 1923 to 2345 423 to 1   fully sequenced,   423/423
(100 %)
0 diff
(100 %id)
AA722132 pineal gland .c-u 1926 to 2356 424 to 1       424/426
(99 %)
8 diff
(98.2 %id)
AA187922   .c-u 1927 to 2346 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AA718965 pineal gland .c-u 1934 to 2357 424 to 1       424/424
(100 %)
3 diff
(99.3 %id)
AV708449 adrenal gland .c-u 1937 to 2345 1 to 409   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 409/409
(100 %)
0 diff
(100 %id)
BI818733 pooled brain, lung, testis .c-u 1938 to 2345 1 to 408   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 408/408
(100 %)
0 diff
(100 %id)
TI_57200019   .c-u 1938 to 2345 65 to 472   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 408/472
(86 %)
6 diff
(98.8 %id)
BP350076 brain .c-u 1939 to 2468 1 to 530       530/581
(91 %)
10 diff
(98.3 %id)
T57342 fetal spleen, Spleen .c-u 1946 to 2331 395 to 1   fully sequenced,   395/395
(100 %)
15 diff
(96.3 %id)
CN266661 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c-u 1948 to 2341 395 to 2     Submitted on the opposite strand 394/428
(92 %)
0 diff
(100 %id)
AA515563 lung, lung tumor .c-u 1953 to 2347 395 to 1       395/395
(100 %)
0 diff
(100 %id)
H80490 liver and spleen .c-u 1954 to 2311 1 to 359   fully sequenced,   359/359
(100 %)
2 diff
(99.5 %id)
T34895 brain .c-u 1955 to 2257 1 to 302       302/302
(100 %)
1 diff
(99.7 %id)
AA477116.
matches multiple genes
ovarian tumor, ovary .c-u 1970 to 2346 377 to 1     also hits gene RPL37A 377/377
(100 %)
5 diff
(98.7 %id)
BM676344 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 1974 to 2345 390 to 19   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 372/380
(97 %)
0 diff
(100 %id)
TI_151775895   .c-u 1974 to 2345 81 to 454   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 374/454
(82 %)
6 diff
(98.7 %id)
AI818756 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c-u 1977 to 2350 374 to 1       374/374
(100 %)
0 diff
(100 %id)
BP396845 pancreatic islet .c-u 1981 to 2351 1 to 371     Submitted on the opposite strand 371/371
(100 %)
0 diff
(100 %id)
N77850 lung .c-u 1984 to 2345 364 to 1   fully sequenced,   364/364
(100 %)
3 diff
(99.2 %id)
BM674318 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 1984 to 2359 380 to 1   fully sequenced,   380/380
(100 %)
3 diff
(99.3 %id)
AA918713 Kidney .c-u 2002 to 2353 352 to 1       352/352
(100 %)
0 diff
(100 %id)
W47524 senescent fibroblast .c-u 2003 to 2350 353 to 1   fully sequenced,   353/353
(100 %)
1 diff
(99.8 %id)
T57834 lung .c-u 2013 to 2351 343 to 1       343/535
(64 %)
6 diff
(98.9 %id)
AA525536 metastatic prostate bone lesion .c-u 2017 to 2350 1 to 335       335/341
(98 %)
6 diff
(98.3 %id)
CA944941 Human Lung Epithelial cells, lung .c-u 2019 to 2345 345 to 19   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 327/436
(75 %)
3 diff
(99.4 %id)
AA813762   .c-u 2027 to 2351 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
EB362282 eye, lens .c-u 2027 to 2669 644 to 1       644/644
(100 %)
5 diff
(99.3 %id)
CB241762 Human Lung Epithelial cells, lung .c-u 2029 to 2283 136 to 390     Submitted on the opposite strand 255/390
(65 %)
9 diff
(97.7 %id)
DB364129   .c-u 2031 to 2345 315 to 1       315/315
(100 %)
8 diff
(97.5 %id)
BU740658 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 2031 to 2359 331 to 1   fully sequenced,   331/331
(100 %)
3 diff
(99.1 %id)
AA576226 breast, breast tumor .c-u 2033 to 2345 313 to 1       313/313
(100 %)
0 diff
(100 %id)
AA888241 metastatic prostate bone lesion .c-u 2037 to 2354 317 to 1       317/324
(97 %)
2 diff
(99.4 %id)
N90392 liver and spleen .c-u 2041 to 2153 1 to 113       113/114
(99 %)
1 diff
(99.2 %id)
H55829 liver and spleen .c-u 2048 to 2344 299 to 1   fully sequenced,   299/299
(100 %)
2 diff
(99.4 %id)
BU566363 mixed (pool of 40 RNAs) .c-u 2055 to 2345 1 to 291   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 291/291
(100 %)
2 diff
(99.4 %id)
AW593638 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c-u 2069 to 2360 292 to 1       292/292
(100 %)
1 diff
(99.7 %id)
TI_149286342   .c-u 2074 to 2676 685 to 84   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 602/1119
(53 %)
6 diff
(99.5 %id)
AA480766 Kidney .c-u 2075 to 2344 270 to 1       270/280
(96 %)
0 diff
(100 %id)
AA444058 ovarian tumor, ovary .c-u 2080 to 2345 266 to 1       266/266
(100 %)
1 diff
(99.7 %id)
T11835   .c-u 2104 to 2298 194 to 4       191/194
(98 %)
11 diff
(94.4 %id)
AA369945 Prostate .c-u 2108 to 2345 238 to 1       238/239
(99 %)
0 diff
(100 %id)
BE827997 lung_tumor .c-u 2110 to 2200 12 to 102       91/102
(89 %)
6 diff
(94.2 %id)
AA081232   .c-u 2125 to 2355 235 to 1       235/237
(99 %)
4 diff
(98.4 %id)
AA916754 carcinoid, lung .c-u 2133 to 2613 1 to 482     Submitted on the opposite strand 482/482
(100 %)
4 diff
(99.2 %id)
TI_149298967   .c-u 2136 to 2676 638 to 97   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 542/968
(55 %)
3 diff
(99.7 %id)
BU684856 lung, Primary Lung Cystic Fibrosis EpithelialCells .c-u 2136 to 2676 560 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 542/550
(98 %)
3 diff
(99.5 %id)
AI457610 pooled .c-u 2138 to 2679 543 to 2       542/543
(99 %)
0 diff
(100 %id)
AA503187 Prostate .c-u 2143 to 2345 8 to 211   AAA Possibly primed on the genome, locally A rich (26/28 A in genome downstream of last aligned base) 204/211
(96 %)
6 diff
(97.2 %id)
AI963197 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c-u 2143 to 2351 209 to 1       209/209
(100 %)
0 diff
(100 %id)
AI985939 four pooled poorly-differentiatedadenocarcinomas, lung .c-u 2143 to 2676 535 to 1       535/535
(100 %)
2 diff
(99.7 %id)
BU752488 placenta .c-u 2147 to 2676 547 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 530/530
(100 %)
0 diff
(100 %id)
N93449 lung .c-u 2167 to 2345 179 to 1       179/180
(99 %)
2 diff
(98.9 %id)
BE349117 malignant melanoma, metastatic to lymphnode, skin .c-u 2167 to 2678 511 to 1       511/511
(100 %)
1 diff
(99.9 %id)
H19743 brain .c-u 2178 to 2346 1 to 169   fully sequenced,   169/169
(100 %)
0 diff
(100 %id)
H46516 brain .c-u 2178 to 2402 1 to 225   fully sequenced,   225/225
(100 %)
1 diff
(99.6 %id)
H50493 brain .c-u 2178 to 2328 1 to 151   fully sequenced,   151/151
(100 %)
0 diff
(100 %id)
H97935 melanocyte .c-u 2178 to 2679 505 to 4       502/505
(99 %)
0 diff
(100 %id)
EL951772 eyeball .c-u 2185 to 2677 1 to 492       492/561
(87 %)
7 diff
(98.8 %id)
BU752425 placenta .c-u 2185 to 2673 510 to 22   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 489/492
(99 %)
0 diff
(100 %id)
H45598 brain .c-u 2189 to 2346 1 to 159       159/159
(100 %)
1 diff
(99.4 %id)
AA503377 colon .c-u 2191 to 2676 487 to 1       487/487
(100 %)
6 diff
(98.8 %id)
BM971945 lung .c-u 2196 to 2676 499 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 481/481
(100 %)
0 diff
(100 %id)
BU944704 adenocarcinoma, cell line, breast .c-u 2197 to 2676 1 to 480   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 480/480
(100 %)
0 diff
(100 %id)
AI804993 Prostate .c-u 2200 to 2677 479 to 1       479/479
(100 %)
2 diff
(99.6 %id)
DB571995 hypothalamus .c-u 2204 to 2676 1 to 472     Submitted on the opposite strand 472/472
(100 %)
1 diff
(99.8 %id)
EC550138 Prostate .c-u 2210 to 2307 1 to 98       98/98
(100 %)
0 diff
(100 %id)
AA470043   .c-u 2214 to 2331 1 to 118   fully sequenced,   118/118
(100 %)
1 diff
(99.2 %id)
AA872841 2 pooled tumors (clear cell type), Kidney .c-u 2214 to 2348 135 to 1       135/135
(100 %)
0 diff
(100 %id)
F25848 pectoral muscle (after mastectomy) .c-u 2218 to 2350 1 to 134       134/134
(100 %)
1 diff
(99.3 %id)
AI885369 anaplastic oligodendroglioma, brain .c-u 2219 to 2676 459 to 1       459/459
(100 %)
1 diff
(99.8 %id)
F37064 pectoral muscle (after mastectomy) .c-u 2221 to 2332 1 to 112       112/112
(100 %)
0 diff
(100 %id)
AI073886 pooled .c-u 2229 to 2677 448 to 1       448/448
(100 %)
2 diff
(99.6 %id)
AA961786 pooled germ cell tumors .c-u 2233 to 2676 446 to 1       446/446
(100 %)
2 diff
(99.6 %id)
AI138573   .c-u 2236 to 2679 445 to 1   tiling clone,   445/445
(100 %)
5 diff
(98.9 %id)
AA682654 liver and spleen .c-u 2240 to 2679 440 to 2       439/441
(99 %)
0 diff
(100 %id)
H80763 melanocyte .c-u 2246 to 2654 410 to 1       410/410
(100 %)
6 diff
(98.6 %id)
AI304691 adenocarcinoma, colon .c-u 2249 to 2675 427 to 1       427/427
(100 %)
1 diff
(99.8 %id)
AA938761 adenocarcinoma, colon .c-u 2250 to 2676 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AI310751 2 pooled tumors (clear cell type), Kidney .c-u 2250 to 2679 432 to 1       432/432
(100 %)
2 diff
(99.6 %id)
AA876026 colon, colon tumor RER+ .c-u 2255 to 2345 90 to 1       90/94
(95 %)
1 diff
(99.0 %id)
AI359891 brain, glioblastoma (pooled) .c-u 2257 to 2669 413 to 1       413/413
(100 %)
1 diff
(99.8 %id)
F26398 pectoral muscle (after mastectomy) .c-u 2259 to 2348 1 to 90       90/90
(100 %)
2 diff
(97.8 %id)
AA737032 germinal center B cell .c-u 2266 to 2679 421 to 7       415/421
(98 %)
0 diff
(100 %id)
AA554326 colon .c-u 2273 to 2677 405 to 1       405/422
(95 %)
1 diff
(99.8 %id)
AI262613 adenocarcinoma, colon .c-u 2280 to 2676 398 to 1       398/401
(99 %)
3 diff
(99.3 %id)
H81408 liver and spleen .c-u 2281 to 2675 406 to 1   fully sequenced,   406/406
(100 %)
9 diff
(97.8 %id)
N24808 melanocyte .c-u 2282 to 2677 397 to 1       397/397
(100 %)
1 diff
(99.8 %id)
EC475047 Prostate .c-u 2290 to 2370 1 to 81       81/97
(83 %)
5 diff
(94.9 %id)
EC518877 Prostate .c-u 2290 to 2348 1 to 59       59/59
(100 %)
2 diff
(96.7 %id)
EC499100 Prostate .c-u 2291 to 2344 1 to 54       54/57
(94 %)
1 diff
(98.3 %id)
H49970 brain .c-u 2298 to 2656 363 to 1   fully sequenced,   363/363
(100 %)
10 diff
(97.3 %id)
AA416950   .c-u 2301 to 2672 373 to 1   fully sequenced,   373/373
(100 %)
2 diff
(99.5 %id)
CN478649 Human Lung Epithelial cells, lung .c-u 2302 to 2657 14 to 373     Submitted on the opposite strand 360/382
(94 %)
9 diff
(97.7 %id)
BP396520 pancreatic islet .c-u 2306 to 2610 1 to 306     Submitted on the opposite strand 306/306
(100 %)
1 diff
(99.7 %id)
AA503714 colon .c-u 2307 to 2675 369 to 1       369/369
(100 %)
2 diff
(99.5 %id)
CU442874 epidermis .c-u 2316 to 2678 14 to 376       363/390
(93 %)
6 diff
(98.5 %id)
AI192161 uterus .c-u 2316 to 2676 374 to 13   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 362/362
(100 %)
1 diff
(99.8 %id)
AI351165 pooled germ cell tumors .c-u 2321 to 2676 355 to 1       355/355
(100 %)
3 diff
(99.2 %id)
CA502827 Human Lung Epithelial cells, lung .c-u 2321 to 2669 14 to 364   AAA Submitted on the opposite strand 351/364
(96 %)
6 diff
(98.4 %id)
H20076 brain .c-u 2328 to 2669 343 to 1   fully sequenced,   343/343
(100 %)
2 diff
(99.5 %id)
N59768 liver and spleen .c-u 2335 to 2669 341 to 1   fully sequenced,   341/341
(100 %)
4 diff
(98.9 %id)
BF095475 uterus_tumor .c-u 2355 to 2581 234 to 5       230/234
(98 %)
0 diff
(100 %id)
AA417273.
matches multiple genes
  .c-u 2364 to 2679 316 to 1     also hits gene FSTL3 316/316
(100 %)
0 diff
(100 %id)
AA837021 lung, small cell carcinoma .c-u 2370 to 2679 315 to 6       310/384
(80 %)
0 diff
(100 %id)
AA679088 liver and spleen .c-u 2372 to 2641 270 to 1     Submitted on the opposite strand 270/270
(100 %)
2 diff
(99.3 %id)
H46517 brain .c-u 2375 to 2630 256 to 1   fully sequenced,   256/256
(100 %)
3 diff
(98.9 %id)
BQ270290 insulinoma, Pancreas .c-u 2375 to 2669 1 to 295   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 295/295
(100 %)
5 diff
(98.4 %id)
AA583534   .c-u 2377 to 2669 1 to 293   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 293/293
(100 %)
6 diff
(98.0 %id)
BM714058 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 2386 to 2676 1 to 291   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 291/291
(100 %)
0 diff
(100 %id)
BM726360 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 2386 to 2676 1 to 291   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 291/291
(100 %)
0 diff
(100 %id)
AA192327 muscle, skeletal muscle .c-u 2392 to 2668 279 to 1       279/447
(62 %)
2 diff
(99.6 %id)
AI928077 normal prostate, Prostate .c-u 2394 to 2676 283 to 1       283/283
(100 %)
0 diff
(100 %id)
AI928676 anaplastic oligodendroglioma, brain .c-u 2399 to 2675 279 to 2       278/279
(99 %)
0 diff
(100 %id)
BF332724 breast .c-u 2400 to 2604 10 to 215       206/215
(95 %)
6 diff
(97.3 %id)
BF332746 breast .c-u 2400 to 2604 11 to 214       204/214
(95 %)
6 diff
(97.2 %id)
BE093838 breast .c-u 2402 to 2604 1 to 203       203/203
(100 %)
2 diff
(99.1 %id)
BE093839 breast .c-u 2402 to 2604 1 to 203       203/203
(100 %)
2 diff
(99.1 %id)
AA662475 normal prostate, Prostate .c-u 2413 to 2679 272 to 6       267/272
(98 %)
0 diff
(100 %id)
AA642684 normal prostate, Prostate .c-u 2414 to 2679 266 to 1       266/266
(100 %)
13 diff
(95.2 %id)
AI523137 aorta .c-u 2416 to 2672 257 to 1       257/257
(100 %)
0 diff
(100 %id)
AW009428 colon .c-u 2418 to 2676 259 to 1       259/259
(100 %)
0 diff
(100 %id)
AI832375 colon .c-u 2419 to 2669 251 to 1       251/251
(100 %)
0 diff
(100 %id)
BQ268345 insulinoma, Pancreas .c-u 2421 to 2676 271 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 256/256
(100 %)
0 diff
(100 %id)
AI669071 Prostate .c-u 2434 to 2676 262 to 20   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 243/243
(100 %)
2 diff
(99.2 %id)
BM822045 stomach .c-u 2463 to 2667 1 to 204       204/204
(100 %)
5 diff
(97.6 %id)
CU448238 epidermis .c-u 2469 to 2582 1 to 114       114/124
(91 %)
11 diff
(91.2 %id)
N68582 liver and spleen .c-u 2472 to 2669 199 to 1       199/199
(100 %)
2 diff
(99.0 %id)
AI204204   .c-u 2495 to 2679 186 to 2       185/186
(99 %)
0 diff
(100 %id)
BM681536 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 2512 to 2676 183 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 165/165
(100 %)
1 diff
(99.4 %id)
BM675243 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 2516 to 2676 179 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 161/161
(100 %)
0 diff
(100 %id)
BP425999 small intestine .c-u 2552 to 2679 1 to 129     Submitted on the opposite strand 129/130
(99 %)
2 diff
(98.5 %id)
CB178497 Pancreas, Purified pancreatic islet .c-u 2553 to 2679 1 to 127   fully sequenced,   127/127
(100 %)
1 diff
(99.3 %id)
N80555.
matches multiple genes
lung .c-u 2567 to 2676 128 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base), also hits gene povor 110/115
(95 %)
0 diff
(100 %id)
CB178738 Pancreas, Purified pancreatic islet .c-u 2598 to 2675 78 to 1   fully sequenced,   78/78
(100 %)
0 diff
(100 %id)
AA977629 Kidney Gene C20orf108, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes